Healthcare information provider Wolters Kluwer Health, US, has announced that its embedded drug data solution, Medi-Span, is releasing a Controlled Substances File to help healthcare organisations meet mandatory US compliance requirements and to support quality assurance programs. The file data assists pharmacies, payers, EMR/CPOE vendors, and hospitals in adhering to prescribing, dispensing, and reporting requirements by identifying controlled substances schedules at the federal, state, and US territory level.
Along with federal regulations of controlled substances through the Drug Enforcement Agency, individual states and US territories may also have their own regulations that may differ from each other and those at the federal level. The Controlled Substances File assists organisations by providing support for compliance at all levels. It also identifies controlled substances by National Drug Code (NDC), enabling compatibility with a variety of databases and drug information systems.
EMR and CPOE vendors and self-programmers can employ the file to develop rules, applications, and reports based on the needs of their users, aiding in the creation of quality assurance programs around controlled substances.
